Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
HPB
Home
HPB
HPB
Type here to filter the list
E136: Prognostic significance of discordant biochemical and pathologic responses following neoadjuvant therapy in patients undergoing resection for pancreatic cancer
Favorite
E137: Arterial divestment in pancreatic cancer surgery
Favorite
E138: Aryl hydrocarbon receptor ligands link cigarette smoke to pathologic inflammation in the pancreas
Favorite
E139: Assessing Treatment Burden during Neoadjuvant Therapy for Gastrointestinal Cancers: A Mixed Methods Analysis
Favorite
E140: Concordance in Oncogenic Alterations between Primary and Recurrent/Metastatic Cholangiocarcinoma Pairs Using Targeted Next-Generation Sequencing
Favorite
E142: Evolving treatment of oligometastatic pancreatic cancer to the liver – Is surgery following induction chemotherapy beneficial?
Favorite
E143: Dissociated Response to Immune Checkpoint Inhibitors: Potential Mechanisms and Role of Surgery
Favorite
E144: Frailty Predicts Loss of Independence after Pancreatic Surgery
Favorite
E146: Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma
Favorite
E147: Impact of neoadjuvant therapy on oncological outcomes of patients with distal pancreatic adenocarcinoma: An intention-to-treat analysis
Favorite
E148: Liver Resection with Extrahepatic Disease: A Population-based Analysis of Thoughtful Selection
Favorite
E150: Single-cell imaging mass cytometry reveals spatially contiguous neutrophil-fibroblast ecosystems as a novel biomarker of chemoresistance in pancreatic cancer
Favorite
E151: Survival for Patients with Radiographically Occult Metastatic Pancreatic Adenocarcinoma in the Era of Modern Multiagent Chemotherapy
Favorite
E152: Sustained epigenetic carcinogenic alteration in hepatocellular carcinoma arising on the liver after viral eradication
Favorite
E153: Unique Molecular Drivers of Pancreatic Cancer among African American Patients
Favorite
E154: Decreasing utilization of surgical and interventional procedures amongst patients with metastatic pancreatic neuroendocrine tumor
Favorite
E155: Analysis of Hospital Costs for Robotic and Open Pancreatectomy at a Cancer Center
Favorite
E156: Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a pancreatic cancer murine model
Favorite
E157: Secreted frizzled related-protein 2 is mechanistically linked to KRAS and tumor fibrosis in pancreatic cancer
Favorite
E158: Long-term Outcomes of Tuberous Sclerosis Complex-associated non-functional Pancreatic Neuroendocrine Tumors
Favorite
E159: Angiogenesis is associated with tumor immunogenicity and immune checkpoint expression in hepatocellular carcinoma
Favorite
E160: Prospective surveillance enriches for resection of malignant high-risk side-branch intraductal papillary mucinous neoplasms
Favorite
E161: Resected Tumor Outcome and Recurrence (RESTORE) Index predicts risk of Hepatocellular Carcinoma Recurrence After Resection
Favorite
E162: Reversing the immunosuppressive tumor microenvironment of fibrolamellar carcinoma
Favorite
E163: Survival Benefit of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer – Need Both Ends of the Sandwich
Favorite
E164: Survival Impact of Neoadjuvant Chemoradiation versus Chemotherapy on Patients with Intrahepatic Cholangiocarcinoma
Favorite
E165: Combined Hepatic Resection and Ablation for Colorectal Liver Metastases Demonstrates Safety and Durable Survival
Favorite
E166: Impact of Operative Time on Open Versus Minimally-Invasive Hepatectomy: A Propensity Matched NSQIP Analysis
Favorite
E167: Impact of Tumor Downstaging after Neoadjuvant Treatment on Overall Survival Among Patients with Pancreatic Ductal Adenocarcinoma: National Cancer Database Analysis
Favorite
E168: Locally Invasive and Metastatic Solid Pseudopapillary Neoplasm of the Pancreas. A Systematic Review and Meta-Analysis of Reported Cases
Favorite
E169: Magnetic resonance-guided radiotherapy provides effective local control and promising outcomes for patients with advanced pancreatic adenocarcinoma
Favorite
E170: Neoadjuvant Therapy Increases Blood Transfusion in Pancreaticoduodenectomy
Favorite
E172: Characterizing Surgical Second Opinions for Patients with Pancreatic Cancer
Favorite
E173: Defining the Role for Palliative Care Referral in Patients with Pancreatic Cancer Undergoing Curative-Intent Surgery: An International Survey of Surgeons and Palliative Care Physicians
Favorite
E174: Evaluation of EGFR as a Resistance Mechanism in the Treatment of Cholangiocarcinoma
Favorite
E175: Expression of spinster homologue 2 (SPNS2) transporter in hepatocellular carcinoma is associated with lymphangiogenesis but decreased cell proliferation and better disease free survival
Favorite
E176: Feasibility of Implantable Microdosing Devices to Perform in vivo Pharmacotyping in Pancreatic Cancer
Favorite
E177: High Mesothelin Expression in Pancreatic Adenocarcinoma is Associated with High Cancer Cell Proliferation and Low Immune Response but Enhanced Sensitivity to Chemotherapy
Favorite
E178: A Prospective Analysis of the Outcomes of Robotic Pancreatectomy for Locally Advanced Pancreatic Cancer (LAPC)
Favorite
E179: Comparative Efficacy of Transarterial Chemoembolization using Doxorubicin, Cisplatin or Streptozocin in Metastatic Pancreatic Neuroendocrine Tumor to the Liver
Favorite
E180: Defining Optimal Duration of Surveillance After Curative Resection for Pancreatic Neuroendocrine Tumor
Favorite
E181: Disease Outcomes of Patients with Hereditary Pancreatic Neuroendocrine Tumors
Favorite
E182: Does Preoperative Biopsy Impact Outcomes of Patients with Pancreatic Ductal Adenocarcinoma Undergoing Upfront Resection?
Favorite
E183: Efficacy of Neoadjuvant Chemotherapy and Radiation in Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma
Favorite
E184: Epicardial Fat Thickness: A Potential Indicator of Cardiac Cachexia in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Favorite
E185: Incorporation of Lymphovascular Invasion Improves American Joint Committee on Cancer 8th Edition Pathologic Staging for Gallbladder Cancer
Favorite
E187: Surgical resection of metastatic high grade gastroenteropancreatic neuroendocrine neoplasms to the liver is associated with improved survival: analysis of the California Cancer Registry
Favorite
E188: The Role of Neoadjuvant Therapy in Early Stage Pancreatic Ductal Adenocarcinoma: an NCDB study
Favorite
E189: Does Hospital Volume Affect Outcomes After Hepato-Pancreatic-Biliary Surgery in the Veterans Affairs System?
Favorite
E190: Effect of surveillance frequency on outcomes after surgical treatment of colorectal liver metastases
Favorite
E191: Elevated CA 19-9 is Associated with Worse Survival in Patients with Resected Ampullary Carcinoma
Favorite
E192: On-Time Receipt of Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma after Distal Pancreatectomy: Does Approach Matter?
Favorite
E193: Pancreatic Resection in Patients Who Decline Transfusion: A Bloodless Perioperative Plan Mitigates Risk Even in Cases with Borderline Resectable and Locally Advanced Pancreatic Cancer
Favorite
E194: Patients Travel Farther for a Whipple at a Robotic Center
Favorite
E195: The impact of biliary microbes on pathological response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma
Favorite
E196: Irreversible Electroporation: A Promising Treatment Option within a Multidisciplinary Approach for Locally Advanced Pancreatic Cancer
Favorite
E197: Liver-directed Therapy of Neuroendocrine Liver Metastases
Favorite
E198: Malignant cystic neoplasms of the pancreas confer superior survival compared to solid pancreatic ductal adenocarcinoma
Favorite
E199: Minimally Invasive Resection for Gallbladder Adenocarcinoma Associate with Survival Benefit
Favorite
E200: Multiagent neoadjuvant chemotherapy compared to upfront surgery in pancreatic cancer of the body and tail
Favorite
E201: Primary Tumor Location and the response of Colorectal Liver Metastasis to Liver Resection and Liver Directed Therapies
Favorite
E202: Prognostic factors after resection of colorectal liver metastases focusing on oxaliplatin-induced liver damage
Favorite
E203: Single cell transcriptomic analysis of human extra- and intra-hepatic cholangiocarcinoma.
Favorite
E204: Long-Term Survival Outcomes Following Robotic Hepatectomy for Malignant Liver Diseases: A Prospective Analysis from a Minimally Invasive Hepatobiliary Program
Favorite
E205: Non-Diagnostic Biopsies of Pancreatic Lesions and Delay in Diagnosis – Does it Matter?
Favorite
E206: Analysis of Hospital Readmissions and the Economic Impact after Robotic Liver Resection for Hepatic Neoplasia
Favorite
E207: Do major complications after pancreatoduodenectomy have an impact on long-term quality of life and functional outcomes?
Favorite
E208: Early experience with the implementation of a hepatic artery infusion program for the treatment of colorectal liver metastases
Favorite
E209: High MKi67 Expression is Associated with Worse Oncologic Outcomes in Hepatocellular Carcinoma
Favorite
E210: Surgical Approach and Length of Stay in Octogenarians Undergoing Pancreatic Resection
Favorite
E211: Timing of Palliative Care Referrals Among Pancreatic Cancer Patients at an Academic Medical Center
Favorite
E212: Trends over Time for Compliance to Lymphadenectomy Threshold for Biliary Tract Cancers
Favorite
E213: 2D and 3D imaging to unravel endocrine Langerhans islet changes in pancreatic cancer
Favorite
E214: Using a Low-Code Data Integration Platform (KNIME) to Support Integrated Genomic and Clinical Data Analysis.
Favorite
E215: Treatment Trends for Stage I and Stage II Pancreatic Cancer from 2011 to 2020: A Retrospective Analysis using the National Cancer Database
Favorite
E216: Neoadjuvant Immunotherapy for DNA Mismatch Repair-Deficient Pancreatic Cancer: A Single Institution Experience
Favorite
GPP15: Two distinct stem cell-like subtypes of resectable hepatocellular carcinoma with clinical significance and their therapeutic potentials
Favorite
P29: Hepatic resection for metastatic pancreatic ductal adenocarcinoma – a prospective single institution pilot study
Favorite
P30: Validating a Genome-wide CRISPR Screen Determining Mechanisms of Drug Resistance in Pancreatic Adenocarcinoma
Favorite
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Favorite
P32: p38 MAPK inhibition reprograms the inflammatory stroma to overcome the immunosuppressive tumor microenvironment in pancreatic cancer
Favorite
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Favorite
P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study
Favorite
P35: Slow Adoption of Observation for Small Pancreatic Neuroendocrine Tumors
Favorite
P36: Campylobacter abundance is associated with an inflammatory immune signature in pancreatic cancer
Favorite
P37: Characterization of Natural Killer and Cytotoxic T Cell Immune Infiltrates in Pancreatic Ductal Adenocarcinoma
Favorite
P38: Dynamic anthropometrics: sarcopenia and survival in pancreatic cancer
Favorite
P39: Effect of Surgical Approach on Early Return to Intended Oncologic Therapy After Resection for Pancreatic Ductal Adenocarcinoma
Favorite
P40: Exosomal isolation of immune checkpoints from pancreatic ductal adenocarcinoma patient-derived organoids
Favorite